Literature DB >> 19490003

Gemcitabine induced digital ischaemia and necrosis.

A Holstein1, R Bätge, E-H Egberts.   

Abstract

A 70-year-old woman presented with a 7-day history of severe pain, paresthesia, oedema, acrocyanosis and punctate haemorrhagic lesions on her fingertips. The complaints began 2 days after the second cycle of a first-line chemotherapy consisting of cisplatin or carboplatin, and gemcitabine due to advanced urothelial carcinoma. At the fingertips of both hands, haemorrhagic and partly ulcerative lesions were found; these were attributed to vascular toxicity of gemcitabine. Therapeutically sympathicolysis by bilateral blockade of the brachial plexus was performed, accompanied by intravenous administration of the prostacyclin analog iloprost, fractionated heparin subcutaneously and oral therapy with corticosteroids and aspirin. Digital amputation could be avoided. Acral ischemia is a rare but probably underreported adverse effect of gemcitabine therapy and a potential source of misdiagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490003     DOI: 10.1111/j.1365-2354.2008.01057.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  Digital ischemic events related to gemcitabine: Report of two cases and a systematic review.

Authors:  Cvetka Grasic Kuhar; Tanja Mesti; Branko Zakotnik
Journal:  Radiol Oncol       Date:  2010-05-03       Impact factor: 2.991

2.  Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial.

Authors:  Martina Vrankar; Matjaz Zwitter; Tanja Bavcar; Ana Milic; Viljem Kovac
Journal:  Radiol Oncol       Date:  2014-11-05       Impact factor: 2.991

Review 3.  Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.

Authors:  Manal M Fardoun; Joseph Nassif; Khodr Issa; Elias Baydoun; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-11-16       Impact factor: 5.810

Review 4.  Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.

Authors:  Magdalena Zaborowska-Szmit; Maciej Krzakowski; Dariusz M Kowalski; Sebastian Szmit
Journal:  J Clin Med       Date:  2020-04-27       Impact factor: 4.241

5.  Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.

Authors:  Margaux Geier; Hélène Babey; Lucie Monceau-Baroux; Gilles Quéré; Renaud Descourt; Divi Cornec; Gilles Robinet
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

6.  Digital ischemia associated with cancer: results from a cohort study.

Authors:  Maëlle Le Besnerais; Sébastien Miranda; Nicole Cailleux; Nicolas Girszyn; Isabelle Marie; Hervé Lévesque; Ygal Benhamou
Journal:  Medicine (Baltimore)       Date:  2014-08       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.